The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.

[1]  J. Haot,et al.  Cholestatic features in focal nodular hyperplasia of the liver. , 2008, Liver.

[2]  A. Phillips,et al.  Polarity of Response to Transforming Growth Factor-β1 in Proximal Tubular Epithelial Cells Is Regulated by β-Catenin* , 2007, Journal of Biological Chemistry.

[3]  Cristel G. Thomas,et al.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.

[4]  A. Buchmann,et al.  Zonal Gene Expression in Mouse Liver Resembles Expression Patterns of Ha-ras and β-Catenin Mutated Hepatomas , 2007, Drug Metabolism and Disposition.

[5]  J. Zucman‐Rossi,et al.  Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. , 2007, Journal of hepatology.

[6]  B. Cieply,et al.  Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. , 2006, Gastroenterology.

[7]  T. Roskams,et al.  Clinicopathological Features of Focal Nodular Hyperplasia-Like Nodules in 130 Cirrhotic Explant Livers , 2006, The American Journal of Gastroenterology.

[8]  D. Rickman,et al.  Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. , 2006, Developmental cell.

[9]  Charles Auffray,et al.  Deciphering cellular states of innate tumor drug responses , 2006, Genome Biology.

[10]  J. Zucman‐Rossi,et al.  Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.

[11]  J. Zucman‐Rossi,et al.  Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. , 2005, Gastroenterology.

[12]  Cristel G. Thomas,et al.  Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas , 2005 .

[13]  M. Sata,et al.  Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules? , 2004, Journal of hepatology.

[14]  I. Wanless.  The pathogenesis of focal nodular hyperplasia of the liver , 2004 .

[15]  C. Sutter,et al.  Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli , 2004, Genes, chromosomes & cancer.

[16]  R. Gebhardt,et al.  Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice. , 2004, Journal of hepatology.

[17]  W. Cong,et al.  Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis , 2004, Journal of Clinical Pathology.

[18]  S. Lepreux,et al.  Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability , 2004, Comparative hepatology.

[19]  V. Paradis,et al.  A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. , 2003, Gastroenterology.

[20]  A. Dhillon,et al.  Focal nodular hyperplasia‐like areas in cirrhosis , 2003 .

[21]  Chi-Hung Lin,et al.  Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization , 2002, Genes, chromosomes & cancer.

[22]  Y. Jeng,et al.  p53 gene and Wnt signaling in benign neoplasms: β‐catenin mutations in hepatic adenoma but not in focal nodular hyperplasia , 2002, Hepatology.

[23]  C. Balabaud,et al.  Diagnosis of focal nodular hyperplasia: not so easy. , 2001, The American journal of surgical pathology.

[24]  D. Stolz,et al.  Changes in WNT/β‐catenin pathway during regulated growth in rat liver regeneration , 2001 .

[25]  M. Kojiro,et al.  Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. , 1998, Journal of hepatology.

[26]  M. Buendia,et al.  Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Nakamura,et al.  Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.

[28]  V. Paradis,et al.  Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X‐chromosome inactivation , 1997, Hepatology.

[29]  M. Gaffey,et al.  Clonal analysis of focal nodular hyperplasia of the liver. , 1996, The American journal of pathology.

[30]  A. Rahmouni,et al.  Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlations , 1995, Hepatology.

[31]  M. Fiorentino,et al.  Focal nodular hyperplasia of the liver: composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules. , 1995, Human pathology.

[32]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[33]  V. Vilgrain,et al.  Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patients. , 1992, Radiology.

[34]  R. Koff.  Tumors of the liver and intrahepatic bile ducts. In Atlas of Tumor Pathology, Second Series, Fasc. 26. By John R. Craig, Robert L. Peters and Hugh A. Edmondson, 280 pp. Washington, DC: Armed Forces Institute of Pathology, 1990. $35.00 , 1991 .

[35]  R. Peters,et al.  Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .

[36]  J. Bilbao,et al.  Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[37]  A. Moorman,et al.  Complementary distribution of carbamoylphosphate synthetase (ammonia) and glutamine synthetase in rat liver acinus is regulated at a pretranslational level. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  A. Rogers,et al.  Gastroenterology. , 1976, Postgraduate medicine.

[39]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[40]  J. Zucman‐Rossi,et al.  Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. , 2008, Journal of hepatology.

[41]  Steven Gallinger,et al.  Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. , 2007, Cancer research.

[42]  R. Nusse,et al.  Wnt signaling in disease and in development , 2005, Cell Research.

[43]  RoelNUSSE.  Wnt signaling in disease and in development , 2005 .

[44]  Cristel G. Thomas,et al.  Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. , 2005, Human molecular genetics.

[45]  G. Michalopoulos,et al.  Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. , 2003, Gastroenterology.

[46]  Jan Kitajewski,et al.  New targets of β-catenin signaling in the liver are involved in the glutamine metabolism , 2002, Oncogene.

[47]  B. Nemes,et al.  TGFβ1 and apoptosis in human hepatocellular carcinoma and focal nodular hyperplasia , 1998 .